BJU Int. 2018 Aug;122(2):173-180. doi: 10.1111/bju.14452.
NICE Advice - Prolaris gene expression assay for assessing long-term risk of prostate cancer progression: © NICE (2016) Prolaris gene expression assay for assessing long-term risk of prostate cancer progression.
[No authors listed]
KEYWORDS:
NICE Guidance
- PMID:
- 30134062
- DOI:
- 10.1111/bju.14452
No hay comentarios:
Publicar un comentario